OPKO Health (Ireland)

OPKO Health (Ireland)

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for OPKO Health (Ireland), Ireland, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

68%


Total
Publications

84


Total Open
Publications

57


Total
Citations

402


Open Access
Percentage

68%


Total
Publications

84


Total Open
Publications

57


Total
Citations

402

Wikipedia

Website

download

Breakdown

52% 9% 3% 36%

Publisher Open

52%

Both

9%

Other Platform Open

3%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0123456789101112Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

24%OA Journal

OA Journal 24%

11

Hybrid 24%

11

No Guarantees 52%

24

Other Platform Open

Domain 55%

6

Institution 36%

4

Preprint 18%

2

Other Internet 9%

1

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
6
Unknown Repository
Other Internet
1
University of Oslo - Duo Research Archive
Institution
1
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
1
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
1
Preprints
Preprint
1
OSF Preprints - Arabixiv
Preprint
1
Nicolaus Copernicus University - Nicolaus Copernicus University Repository
Institution
1
National Research Technological University - Известия Высших Учебных Заведений. Черная Металлургия
Institution
1
Europe PMC
Domain
1
1 / 2

Data updated 18 August 2025

Share

Share

Share